tirzepatide how much weight loss in first month is FDA-approved for management, with clinical trials showing average weight of 15–22.5% over 72 weeks. It's a prescription-only therapy, meaning it's not for everyone, and it works by acting Everyone Wants to Lose 20

Although the use of GLP-1 RAs prior to EGD or colonoscopy has resulted in poor outcomes in terms of poor visibility/preparation scores and the need for aborted/repeated procedures, their use prior to concurrent EGD and colonoscopy might not have the same detrimental effect

Comparing Tirzepatide and Semaglutide for Users In Fullerton, CA Effectiveness Both medications have shown impressive results in clinical trials

GLP-1s should only be used under the supervision of a licensed healthcare provider because they may cause gastrointestinal side effects, gallbladder disease, and, rarely, pancreatitis or thyroid C-cell tumors

Annals of the Rheumatic Diseases, 68(7), 1119-1124

Protocol 2: Companion to GLP-1 medication Goal: Reduce GLP-1 medication side effects and support gut health during treatment